Form 4: Geron Corp Director Acquires Stock Options
Statement of Changes in Beneficial Ownership
Geron Corporation director Susan Molineaux has acquired 220,000 stock options, with vesting contingent on continuous service and company meeting dates.
Summary
- Susan Molineaux, a Director at Geron Corporation, was granted 220,000 stock options on May 20, 2026.
- These options have a strike price of $1.26 and an expiration date of May 19, 2036.
- The options will vest and become exercisable on the earlier of the next annual meeting or the first anniversary of the grant date, provided Molineaux remains in continuous service.
- This filing is made under Section 16(a) of the Securities Exchange Act of 1934, indicating changes in beneficial ownership.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard stock option grant to a director rather than a significant financial event or strategic shift.
Positives
- Director Molineaux has been granted a significant number of stock options, aligning her interests with shareholders.
- The grant of options suggests confidence in the company's future prospects by management and the board.
Risks
- The vesting of options is contingent on Molineaux's continuous service, implying a potential risk if she departs the company before vesting.
- The value of the options is subject to the future performance of Geron Corporation's stock price.
Future Outlook
The vesting schedule for the stock options indicates a forward-looking perspective, tying compensation to continued service and future company events such as the next annual meeting.
Industry Context
StockSavvy.ai notes that the granting of stock options to directors is a common practice in the biotechnology and pharmaceutical sectors, including Geron Corporation, to incentivize long-term performance and align executive interests with shareholder value.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney | Susan Molineaux has granted power of attorney to Michelle Robertson, Ankita Patel, Agnieszka Cieplinska, and Katie Harmon to execute Forms 3, 4, and 5 on her behalf. | 2026-01-29 | Facilitates timely and accurate reporting of beneficial ownership changes, ensuring compliance with SEC regulations. |
Stakeholder Impact
- Shareholders: The option grant aligns director compensation with potential future stock performance, which can benefit shareholders if the stock price increases.
- Employees: The continuous service requirement for vesting may indirectly impact employee retention efforts if it sets a precedent for other equity awards.
- Management: The filing details a standard compensation practice for directors.
Next Steps
- Susan Molineaux will continue her service with Geron Corporation.
- The stock options will vest according to the specified schedule.
- Further transactions by Molineaux will be reported on subsequent SEC filings.
Key Dates
| Date | Description |
|---|---|
| 01/29/2026 | Date of execution for the Power of Attorney document. |
| 05/19/2036 | Expiration date of the granted stock options. |
| 05/20/2026 | Transaction date for the acquisition of stock options. |
| 05/26/2026 | Date of signature for the Form 4 filing. |
Keywords
Geron Corporation, GERN, Form 4, Stock Options, Beneficial Ownership, Director, SEC Filing, Insider Trading, Equity Award
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.